Target intelligence / Profile preview

Neurite outgrowth promotion

Molecular classification
Biological process, Other
01

Overview

Neurite outgrowth promotion refers to the complex biological process where neurons extend axons and dendrites to establish or restore neural connectivity. Rather than being a single molecular target, it is a phenotypic outcome regulated by a diverse array of receptors, extracellular matrix proteins, and intracellular signaling pathways (PMC3491475). In the developing nervous system, this process is essential for proper brain architecture, while in adults, it is a critical target for therapeutic intervention following spinal cord injury or during the progression of neurodegenerative diseases like Alzheimer's (NIH, 2023). Pharmacological enhancement of neurite outgrowth often involves the use of neurotrophic factors such as Nerve Growth Factor (NGF) or the inhibition of growth-inhibitory proteins such as Nogo and Rho-associated protein kinase (ROCK) (PMID: 15103400). While the promotion of this process offers significant potential for neurorestoration, it must be precisely regulated to prevent misdirected connections or hypersensitivity issues. Current research focuses on small molecule mimetics and gene therapy to overcome the inhibitory environment of the adult central nervous system.

Other names
AxonogenesisNeuritogenesisAxonal growthNeurite extensionNeurite sprouting
02

Mechanism of action

Neurite outgrowth promotion is achieved by activating pro-growth signaling pathways, such as the MAPK/ERK or PI3K/Akt cascades via neurotrophin receptors (e.g., TrkA, TrkB), or by inhibiting inhibitory signals like the Nogo-A/Rho/ROCK pathway that normally arrest axonal extension (PMID: 16858392; PMID: 22444245).

03

Biological functions

NeurogenesisAxonal regenerationSynaptogenesisCell differentiationSignal transduction
04

Disease associations

Neurodegenerative diseaseSpinal cord injuryTraumatic brain injuryStrokeAlzheimer's diseaseParkinson's disease
05

Safety considerations

Risk of aberrant axonal sprouting leading to neuropathic painPotential for oncogenic transformation due to chronic growth factor pathway activationDifficulty in localized delivery and blood-brain barrier penetrationPotential for inflammatory responses in the central nervous system
06

Interacting drugs

Nerve growth factor (NGF)

4 more in the full profile.

07

Biomarkers

Growth Associated Protein 43 (GAP-43)Beta-III tubulin (Tuj1)Microtubule-associated protein 2 (MAP2)Neurofilament light chain (NfL)

Beyond the preview

Go deeper on Neurite outgrowth promotion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurite outgrowth promotion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call